Table 1.
Prevalence rate of HBV & HCV positivity among HIV+ patient
| HBsAg+ | Anti-HCV+ | Double Positive | |||||
|---|---|---|---|---|---|---|---|
| Variable | N (Percent) | N | P | N | P | N | P |
| Total | 391(100%) | 57(14.5%) | 282 (72%) | 31 (7.9%) | |||
| Sex | <0.001 | <0.001 | <0.001 | ||||
| Male | 358 (91.6%) | 40(11.2%) | 274(76.5%) | 24 (6.7%) | |||
| Female | 33 (8.4%) | 17(51.5%) | 8 (24.3%) | 7 (21.2%) | |||
| Age | 0.013 | <0.001 | <0.001 | ||||
| ≤ 30 | 140 (35.8%) | 18(12.9%) | 108 (77.2%) | 8 (5.7%) | |||
| 31-50 | 204 (52.1%) | 27(13.2%) | 151 (74%) | 18 (8.9%) | |||
| ≥ 50 | 47 (12%) | 12(25.5%) | 23 (48.9%) | 5 (10.6%) | |||
| Marital status | <0.001 | <0.001 | <0.001 | ||||
| Single | 195 (49.8%) | 14(7.2%) | 160 (82%) | 11(5.7%) | |||
| Married | 166 (42.4%) | 40(24%) | 99 (59.7%) | 18 (10.6%) | |||
| Other | 30 (7.6%) | 3 (10%) | 23 (76.7%) | 2 (6.7%) | |||
| Risk Factor | <0.001 | <0.001 | <0.001 | ||||
| IDU | 202 (51.6%) | 12 (5.9%) | 172 (85.2%) | 8 (3.1%) | |||
| Sexual | 11 (2.8%) | 4 (3.4%) | 3 (27.3%) | 1 (9%) | |||
| Transfusion | 12 (3%) | 0 (0%) | 12 (100%) | 0 (0%) | |||
| Sex & IDU | 56 (14.3%) | 6 (10.7%) | 36 (64.3%) | 13(23.2%) | |||
| Pregnant | 5 (1.2%) | 2 (40%) | 0 (0%) | 0 (0%) | |||
| Other | 105 (26.8%) | 33(31.5%) | 59 (56.2%) | 9 (8.6%) | |||
| Occupation | <0.001 | <0.001 | <0.001 | ||||
| Unemployed | 221 (56.5%) | 16 (7.2%) | 174 (78.7%) | 15 (6.8%) | |||
| Self employed | 63 (16.1%) | 8 (12.7%) | 47 (74.6%) | 4 (6.3%) | |||
| Worker | 42)10.7%) | 6 (14.3%) | 33 (78.6%) | 3 (7.2%) | |||
| Employee | 3 (0.7%) | 1) 33.3%) | 2 (66.7%) | 0) 0%) | |||
| housewife | 32 (8.1%) | 16 (50%) | 8) 25%) | 7 (21.9%) | |||
| Farmer | 4 (1%) | 4 (100%) | 0 (0%) | 0 (0%) | |||
| Student | 12 (3%) | 3 (25%) | 9 (75%) | 0 (0%) | |||
| Driver | 10 (2.5%) | 2 (20%) | 6 (60%) | 20 (20%) | |||
| Other | 4 (1%) | 1 (25%) | 3 (75%) | 0 (0%) | |||
HBsAg: HBV surface antigen, anti-HCV: antibody against HCV, N: number of patients, p: p-value, IDU: Injection drugs users